Acute kidney injury

Short-term statin therapy for prevention of contrast-induced AKI

Two recent studies suggest that periprocedural statin administration can prevent contrast-induced acute kidney injury in cardiac patients undergoing percutaneous coronary intervention and in renal patients undergoing angiography, with or without intervention. These studies support the routine administration of potent statins before contrast media infusion in these vulnerable patients.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    McCullough, P. A. et al. Epidemiology and prognostic implications of contrast-induced nephropathy. Am. J. Cardiol. 98, 5K–13K (2006).

    CAS  Article  Google Scholar 

  2. 2

    Chang, C. F. & Lin, C. C. Current concepts of contrast-induced nephropathy: a brief review. J. Chin. Med. Assoc. http://dx.doi.org/10.1016/j.jcma.2013.08.011.

  3. 3

    Han, Y. et al. Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease. J. Am. Coll. Cardiol. http://dx.doi.org/10.1016/j.jacc.2013.09.017.

  4. 4

    Leoncini, M. et al. Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome. Results from protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome (PRATO-ACS study). J. Am. Coll. Cardiol. http://dx.doi.org/10.1016/j.jacc.2013.04.105.

  5. 5

    Ho, J. E. et al. Relation of improvement in estimated glomerular filtration rate with atorvastatin to reductions in hospitalizations for heart failure (from the treating to new targets [TNT] study). Am. J. Cardiol. 109, 1761–1766 (2012).

    CAS  Article  Google Scholar 

  6. 6

    Athyros, V. G., Karagiannis, A., Katsiki, N. & Mikhailidis, D. P. Relation of improvement in glomerular filtration rate with atorvastatin to reductions in heart failure morbidity. Am. J. Cardiol. 110, 763 (2012).

    Article  Google Scholar 

  7. 7

    Quintavalle, C. et al. Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury. Circulation 126, 3008–3016 (2012).

    CAS  Article  Google Scholar 

  8. 8

    Patti G. et al. Short-term, high-dose atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial). Am. J. Cardiol. 108, 1–7 (2011).

    CAS  Article  Google Scholar 

  9. 9

    McCullough, P. A. Contrast-induced acute kidney injury. J. Am. Coll. Cardiol. 51, 1419–1428 (2008).

    Article  Google Scholar 

  10. 10

    Pasceri, V. et al. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (atorvastatin for reduction of myocardial damage during angioplasty) study. Circulation 110, 674–678 (2004).

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Dimitri P. Mikhailidis.

Ethics declarations

Competing interests

D. P. Mikhailidis has given talks, attended conferences and participated in trials and advisory boards sponsored by MSD and Genzyme. V. G. Athyros declares no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Mikhailidis, D., Athyros, V. Short-term statin therapy for prevention of contrast-induced AKI. Nat Rev Nephrol 10, 8–9 (2014). https://doi.org/10.1038/nrneph.2013.249

Download citation

Further reading